Home › Cutaneous T-Cell Lymphoma › Michigan
Cutaneous T-Cell Lymphoma clinical trials in Michigan
3 studies for Cutaneous T-Cell Lymphoma are looking for participants at sites in Michigan.
Cities in Michigan
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
- University of Michigan, Ann Arbor
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT07195916Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas
- University of Michigan Comprehensive Cancer Center, Ann Arbor
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 5, 2026 · NCT05956041Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
- University of Michigan, Ann Arbor
- Barbara Ann Karmanos Cancer Institute Wayne State University, Detroit
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 22, 2025 · NCT04234048From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.